The D allele of the angiotensin-converting enzyme insertion/deletion (I/D) polymorphism is a risk factor for type 2 diabetes in a population-based Japanese sample

Endocrine Journal

Volumn 50, Issue 4, 2003, Pages 393-398

  Daimon, Makoto ^a   Oizumi, Toshihide ^a   Saitoh, Tamotsu ^a   Kameda, Wataru ^a   Hirata, Akihiko ^a   Yamaguchi, Hiroshi ^a   Ohnuma, Hiroshi ^a   Igarashi, Masahiko ^a   Tominaga, Makoto ^a   Kato, Takeo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

ACE; Diabetes; I D polymorphism; Population based study; Relative risk

Indexed keywords

CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGE; ALLELE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GENDER; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC TRAIT; GENOTYPE; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; DNA TRANSPOSABLE ELEMENTS; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK;

EID: 12444310106     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.50.393     Document Type: Article

References (28)

1. Costerousse O, Danilov S, Alhenc-Gelas F (1997) Genetics of angiotensin I-converting enzyme. Clin Exp Hypertens 19: 659-669.
2. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346.
3. Nakajima S, Baba T, Yajima Y (1996) Is ACE gene polymorphism a useful marker for diabetic alubuminuria in Japanese NIDDM patients? Diabetes Care 19: 1420-1422.
4. Ohno T, Kawazu S, Tomono S (1996) Association analysis of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetes. Metabolism 45: 218-222.
5. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, Cambien F, Passa P, Alhenc-Gelas F (1994) Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384-388.
6. Kunz R, Bork JP, Fritsche L, Ringel J, Sharma AM (1998) Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systemic review. J Am Soc Nephrol 9: 1653-1663.
7. Dudley CRK, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ (1995) UK prospective diabetes study XV: relationship of renin-anigiotensin system gene polymorphism with microalubuminuria in NIDDM. Kidney Int 48: 1907-1911.
8. Kennon B, Petrie JR, Small M, Connell JMC (1999) Angiotensin-converting enzyme gene and diabetes mellitus. Diabet Med 16: 448-458.
9. Jeffers BW, Estacio RO, Raynolds MV, Schrier RW (1997) Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int 52: 473-477.
10. Cambien F, Poirier O, Lecerf L, Evance A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641-644.
11. Ruiz J, Blanché H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P (1994) Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91: 3662-2665.
12. Fujisawa T, Ikegami H, Shen GQ, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Rakugi H, Higaki J (1995) AngiotensinI-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 18: 983-985.
13. Kogawa K, Nishizawa Y, Hosoi M, Kawagishi T, Maekawa K, Shoji T, Okuno Y, Morii H (1997) Effect of polymorphism of apolipoprotein E and angiotension-converting enzymes genes on arterial wall thickness. Diabetes 46: 682-687.
14. Taniwaki H, Kawagishi T, Emoto M, Shoji T, Hosoi M, Kogawa K, Nishizawa Y, Morii H (1999) Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes. Diabetes Care 22: 1858-1864.
15. Bengtsson K, Orho-Melander M, Lindblad U, Melander O, Bog-Hansen E, Ranstam J, Groop L (1999) Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg hypertention and diabetes project. J Hypertens 17: 1569-1575.
16. Dragovic T, Minshall R, Jackman HL, Wang LX, Erdos EG (1996) Kininase II-type enzymes; their putative role in muscle energy metabolism. Diabetes 45: S34-S37.
17. Jonsson JR, Game PA, Head RJ, Frewin DB (1994) The expression and localization of the angiotensin-converting enzyme mRNA in human adipose tissue. Blood Press 3: 72-75.
18. Dietze G, Wicklmayr M, Bottger I, Schifmann R, Geiger R, Fritz H, Mehnert H (1980) The kallikreinkinin system and muscle metabolism: biochemical aspects. Agents Actions 10: 334-343.
19. Henriksen EJ, Jacob S (1995) Effect of captopril on glucose transport activity in skeletal muscle of obese Zuker rats. Metabolism 44: 267-272.
20. Goldman J, Pfister D, Vukmirovich R (1987) Potentiation of insulin stimulation of hexose transport by kallikrein and bradykinin in isolated rat adipocytes. Mol Cell Endocrinol 50: 183-191.
21. Hennes MM, O'Shaughnessy IM, Kelly TM, LaBelle P, Egan BM, Kissebah AH (1996) Insulin-resistant lipolysis in abdominally obese hypertensive individuals: role of the renin-angiotensin system. Hypertension 28: 120-126.
22. Oizumi T, Daimon M, Saitoh T, Kameda W, Yamaguchi H, Ohnuma H, Igarashi M, Eguchi H, Manaka H, Tominaga M, Kato T (2001) Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the b3-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample. Diabetes Care 24: 1579-1583.
23. World Health Organization: Diabetes mellitus. Geneva, World Health Org., 1985 (Tech. Report. Ser. No. 727)
24. Jebb SA, Cole TJ, Doman D, Murgatroyd PR, Prentice AM (2000) Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model. Br J Nutr 83: 115-122.
25. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH (1995) A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. New Engl J Med 332: 706-711.
26. Rieder MJ, Taylor SL, Clark AG, Nickerson DA (1999) Sequence variation in the human angiotensin converting enzyme. Nature Genet 22: 59-62.
27. Hammsom L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmäki K, Dahlöf B, de Faire U, Mörlin C, Karlberg BE, Wester PO, Björck JE (1999) Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captoril prevention project (CAPPP) randomised trial. Lancet 353: 611-616.
28. Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BHR, Zinman B (2001) Ramipril and the development of diabetes. JAMA 286: 1882-1885.